Influence of lisinopril on cardiac remodeling induced by tobacco smoke exposure

Case Reports and Clinical Practice Review

Volumn 16, Issue 8, 2010, Pages

  Duarte, Daniella R ^a   Minicucci, Marcos F ^a   Azevedo, Paula S ^a   Chiuso Minicucci, Fernanda ^a   Matsubara, Beatriz B ^a   Matsubara, Luiz S ^a   Campana, Álvaro O ^a   Paiva, Sergio A R ^a   Zornoff, Leonardo A M ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Heart failure; Hypertrophy; Smoking; Ventricular function

Indexed keywords

COLLAGEN; CONNEXIN 43; CYTOKINE; GAMMA INTERFERON; LISINOPRIL; TUMOR NECROSIS FACTOR ALPHA; CIGARETTE SMOKE; TOBACCO SMOKE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXPOSURE; HEART DISEASE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE CONTRACTION; HEART MUSCLE CELL; MALE; NONHUMAN; PROTEIN LOCALIZATION; RAT; SMOKING; SYSTOLIC BLOOD PRESSURE; TAIL; CARDIOVASCULAR PARAMETERS; DRUG EFFECT; HEART CONTRACTION; HEART FUNCTION; HEART LEFT VENTRICLE; HEART VENTRICLE SIZE; MUSCLE CELL; ANIMAL; ECHOCARDIOGRAPHY; HEART VENTRICLE REMODELING; PASSIVE SMOKING; WISTAR RAT;

ANIMALS; ECHOCARDIOGRAPHY; LISINOPRIL; MALE; RATS; RATS, WISTAR; TOBACCO SMOKE POLLUTION; VENTRICULAR REMODELING;

EID: 77956208051     PISSN: 15076164     EISSN: 16433742     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Pfeffer MA, Braunwald E: Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation, 1990; 81: 1161-72
2. Cohn JN, Ferrari R, Sharpe N: Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol, 2000; 35: 569-82
3. Cooper SA, Whaley-Connell A, Habibi J et al: Renin-angiotensinaldosterone system and oxidative stress in cardiovascular insulin resistance. Am J Physiol Heart Circ Physiol, 2007; 293: H2009-23
4. Abdulla J, Barlera S, Latini R et al: A systematic review: Effect of angiotensin converting enzyme inhibition on left ventricular volumes and ejection fraction in patients with a myocardial infarction and in patients with left ventricular dysfunction. Eur J Heart Fail, 2007; 9: 129-35
5. Plante E, Gaudreau M, Lachance D et al: Angiotensin-converting enzyme inhibitor captopril prevents volume overload cardiomyopathy in experimental chronic aortic valve regurgitation. Can J Physiol Pharmacol, 2004; 82: 191-99
6. Olivares EL, Costa-E-Sousa RH, Werneck-de-Castro JP et al: Cellular cardiomyoplasty in large myocardial infarction: Can the beneficial effect be enhanced by ACE-inhibitor therapy? Eur J Heart Fail, 2007; 9: 558-67
7. Paiva SA, Zornoff LA, Okoshi MP et al: Behavior of cardiac variables in animals exposed to cigarette smoke. Arq Bras Cardiol, 2003; 81: 221-28
8. Castardeli E, Paiva SA, Matsubara BB et al: Chronic cigarette smoke exposure results in cardiac remodeling and impaired ventricular function in rats. Arq Bras Cardiol, 2005; 84: 320-24
9. Zornoff LA, Matsubara LS, Matsubara BB et al: Beta-carotene supplementation attenuates cardiac remodeling induced by one-month tobacco-smoke exposure in rats. Toxicol Sci, 2006; 90: 259-66
10. Castardeli E, Duarte DR, Minicucci MF et al: Exposure time and ventricular remodeling induced by tobacco smoke exposure in rats. Med Sci Monit, 2008; 14(3): BR62-66
11. Castardeli E, Duarte DR, Minicucci MF et al: Tobacco smoke-induced left ventricular remodeling is not associated with metalloproteinase-2 or -9 activation. Eur J Heart Fail, 2007; 9: 1081-85
12. Houdi AA, Dowell RT, Diana JN: Cardiovascular responses to cigarette smoke exposure in restrained conscious rats. J Pharmacol Exp Ther, 1995; 275: 646-53
13. Gu L, Pandey V, Geenen DL et al: Cigarette smoke-induced left ventricular remodeling is associated with activation of mitogen-activated protein kinases. Eur J Heart Fail, 2008; 10: 1057-64
14. Rajikin MH, Latif ES, Mar MR et al: Deleterious effects of nicotine on the ultrastructure of oocytes: Role of gamma-tocotrienol. Med Sci Monit, 2009; 15(12): BR378-83
15. Fujita M, Nakanishi Y: The pathogenesis of COPD: lessons learned from in vivo animal models. Med Sci Monit, 2007; 13(2): RA19-24
16. Hays JT, Dale LC, Hurt RD, Croghan IT: Trends in smoking-related diseases. Why smoking cessation is still the best medicine. Postgrad Med, 1998; 104: 56-62, 65-66, 71
17. Zornoff LAM, Matsubara BB, Matsubara LS et al: Early rather than delayed administration of lisinopril protects the heart after myocardial infarction in rats. Basic Res Cardiol, 2000; 95: 208-14
18. Minicucci MF, Azevedo PS, Paiva SA, Zornoff LA: Cardiovascular remodeling induced by passive smoking. Inflamm Allergy Drug Targets, 2009; 8: 334-39
19. Lang RM, Bierig M, Devereux RB et al: Chamber Quantification Writing group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr, 2005; 18: 1440-63
20. Saffitz JE, Green KG, Kraft WJ et al: Effects of diminished expression of connexin 43 on gap junction number and size in ventricular myocardium. Am J Physiol, 2000; 278: H1662-70
21. Kostin S, Rieger M, Dammer S et al: Gap junction remodeling and altered connexin 43 expression in the failing human heart. Mol Cell Biochem, 2003; 242: 135-44
22. Ambrose JA, Barua RS: The pathophysiology of cigarette smoking and cardiovascular disease. J Am Coll Cardiol, 2004; 43: 1731-37
23. Duarte DR, Oliveira LC, Minicucci MC et al: Effects of the administration of beta-blockers on ventricular remodeling induced by cigarette smoking in rats. Arq Bras Cardiol, 2009; 92: 443-47
24. Mehta PK, Griendling KK: Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol, 2007; 292: C82-97
25. Teunissen BEJ, Jongsma HJ, Bierhuizen MFA: Regulation of myocardial connexins during hypertrophic remodeling. Eur Heart J, 2004; 25: 1979-89
26. Severs NJ, Bruce AF, Dupont E, Rothery S: Remodeling of gap junctions and connexin expression in diseased myocardium. Cardiovasc Res, 2008; 80: 9-19
27. Vetterlein F, Mühlfeld C, Cetegen C et al: Redistribution of connexin43 in regional acute ischemic myocardium: influence of ischemic preconditioning. Am J Physiol Heart Circ Physiol, 2006; 291: H813-19
28. Mann DL: Tumor necrosis factor-induced signal transduction and left ventricular remodeling. J Card Fail, 2002; 8(Suppl.6): S379-84
29. Kyriakides ZS, Kremastinos DT, Rentoukas E et al: Acute effects of cigarette smoking on left ventricular diastolic function. Eur Heart J, 1992; 13: 743-48
30. Rosen BD, Saad MF, Shea S et al: Hypertension and smoking are associated with reduced regional left ventricular function in asymptomatic individuals: the Multi-Ethnic Study of Atherosclerosis. J Am Coll Cardiol, 2006; 47: 1150-58
31. Gidding SS, Xie X, Liu K et al: Cardiac function in smokers and nonsmokers: the CARDIA study. The Coronary Artery Risk Development in Yong Adults Study. J Am Coll Cardiol, 1995; 26: 211-16